SLC1A3 Gene Episodic Ataxia Type 6 Genetic Test
Test Name: SLC1A3 Gene Episodic ataxia type 6 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for SLC1A3 Gene Episodic ataxia type 6 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC1A3 Gene Episodic ataxia type 6.
Test Details: The SLC1A3 gene is associated with Episodic Ataxia Type 6 (EA6), a rare neurological disorder that affects coordination and balance. NGS (Next Generation Sequencing) genetic testing can be used to analyze the SLC1A3 gene for mutations or variations that may cause EA6. This type of testing can identify specific genetic changes that may be responsible for the disorder, allowing for earlier diagnosis and more targeted treatment options. NGS genetic testing is a powerful tool for identifying genetic causes of disease, and can help improve patient outcomes through personalized medicine.
Test Name | SLC1A3 Gene Episodic ataxia type 6 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC1A3 Gene Episodic ataxia type 6 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC1A3 Gene Episodic ataxia type 6 |
Test Details |
The SLC1A3 gene is associated with Episodic Ataxia Type 6 (EA6), a rare neurological disorder that affects coordination and balance. NGS (Next Generation Sequencing) genetic testing can be used to analyze the SLC1A3 gene for mutations or variations that may cause EA6. This type of testing can identify specific genetic changes that may be responsible for the disorder, allowing for earlier diagnosis and more targeted treatment options. NGS genetic testing is a powerful tool for identifying genetic causes of disease, and can help improve patient outcomes through personalized medicine. |